Amgen wins patent block on Sanofi drug rival
15 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Amgen has successfully blocked the manufacture, sales and marketing of its Sanofi drug rival in Germany.
List view / Grid view
Patents
Patent litigation for adalimumab resolved in the US
24 May 2019 | By European Pharmaceutical Review
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
Legal ruling confirms that ‘routine’ discoveries can be patented
29 April 2019 | By European Pharmaceutical Review
In a ruling handed down by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be inventive and rewarded with a patent.
Discoveries made through ‘routine’ research can now be patentable
28 March 2019 | By European Pharmaceutical Review
In a ruling handed down on 27 March 2019 by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be rewarded with a patent...
Expert view: The QC micro labs have grown to tackle new challenges
29 October 2018 | By Charles River
Timelines, budgets and regulatory constraints have grown alongside that of the Quality Control (QC) lab’s position in drug development. The main goal of the lab and more widely of the manufacturing industry is to increase safety for the end user and guarantee patients’ health...
Pharma patent challenges for 2018
2 January 2018 | By Christof Hohne
Christof Hohne, partner at patent law firm EIP, discusses second medical use claims and compulsory licences...
Sandoz receives EU approval in Europe for Rixathon (biosimilar rituximab)
3 July 2017 | By Niamh Marriott (European Pharmaceutical Review)
The EC has approved Sandoz’ Rixathon (biosimilar rituximab) for use in Europe. Rixathon is approved for use in all indications of the reference medicine...
Pharma Digitalisation: Challenges and opportunities in transforming the pharma industry
30 May 2017 | By Pasi Kemppainen, Executive Consultant, Pharma Digitalisation and Sammeli Liikkanen, Chief Digital Officer, Orion Pharma
Pharma Digitalisation Executive Consultant, Pasi Kemppainen, and Orion’s CDO Sammeli Liikkanen talk technologies, challenges and opportunities with the digitalisation of pharma…
Patent library will be founded in Lithuania
23 May 2017 | By Niamh Marriott, Junior Editor
The State Patent Bureau of the Republic of Lithuania (SPB) and Kaunas University of Technology National Innovation and Entrepreneurship Centre (KTU NIEC) has signed the collaboration agreement, which laid foundation for the new Patent Library – PATLIB Centre. This will be the first time, when a PATLIB Centre is established…
Opening life sciences’ Unified Patent Court war chest
11 October 2016 | By Vanessa Rieu and Annsley Merelle Ward
Vanessa Rieu and Annsley Merelle Ward explain how life sciences companies can leverage their knowledge of national patent laws in a post-Brexit Europe...
Patient trial and appeal board upholds validity of Shire’s patent
6 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Patent Trial and Appeal Board (PTAB) found that the patent was valid in light of the challenges put forward by the petitioner...
Pharmaceutical patents: Clear the way but careful where you tread
27 September 2016 | By Dominic Adair and Emma Muncey, Bristows
Top litigators Dominic Adair and Emma Muncey review patent court cases to identify the legal steps you should take when marketing a biosimilar...
Shire wins Lialda patent trial against Watson
29 March 2016 | By Victoria White
The US District Court for Southern Florida has upheld Shire's patent for Lialda (mesalamine) delayed release tablets for adults with ulcerative colitis...
Allergan files ANDA to the FDA for generic Abraxane
17 March 2016 | By Victoria White
Allergan believes it is a first applicant to file an ANDA for generic Abraxane and, should it be approved, may get 180 days of generic market exclusivity...